Astrazeneca Pharma India Ltd.

5566.30 +104.95 ▲1.9%

27 February 2024, 04:01:00 PM
Volume: 592

Company Profile

Sector Healthcare Sector Icon Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Industry Icon Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.astrazenecaindia.com/india
Market Cap 13,974.88 Cr.
Enterprise Value(EV) 13,133.12 Cr. 2023-09
Financial Indicators
Earnings per share (EPS) 55.72 Trailing Twelve Months Ending 2023-12
Price-Earning Ratio (PE) 100.32 Trailing Twelve Months Ending 2023-12
Industry PE 41.67 Trailing Twelve Months Ending 2023-12
Book Value / Share 268.31 Trailing Twelve Months Ending 2023-12
Price to Book Value 20.83 Calculated using Price: 5,589.95
Dividend Yield 0.29 Period Ending 2023-03
No. of Shares Subscribed 2.50 Cr. 25,000,000 Shares
FaceValue 2
About Astrazeneca Pharma India Ltd.
The Company is engaged in the business of manufacture, distribution and marketing of life-changing medicines in crucial areas of healthcare including oncology, cardiovascular, diabetes, renal, metabolic and respiratory. The company has an innovative portfolio in crucial areas of healthcare including cardiovascular, renal & metabolic diseases, oncology and respiratory. AstraZeneca Pharma India is a subsidiary of AstraZeneca Pharmaceuticals AB, Sweden, which is an indirect subsidiary of AstraZeneca PLC.

Astrazeneca Pharma India Ltd. Delivery

Delivered Qty
Traded Qty

Astrazeneca Pharma India Ltd. Performance

1 Day
+1.92%
1 Week
+1.23%
1 Month
-11.80%
3 Month
+19.69%
6 Month
+34.03%
1 Year
+65.89%
2 Year
+109.24%
5 Year
+199.50%
10 Year
+558.46%

Astrazeneca Pharma India Ltd. Fundamental Ratios

9 years 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03 2023-03
Return on Equity (%) -12.93 3.43 10.63 11.12 20.03 21.83 22.83 12.78 18.13
Return on Capital Employed (%) -12.93 3.76 18.74 18.65 26.53 34.61 31.24 17.36 24.49
Return on Assets (%) -5.04 1.25 4.25 4.76 9.34 10.57 11.31 6.65 9.37

Astrazeneca Pharma India Ltd. Balance Sheet

Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-09* Rs. Cr.
Shh. Funds 151 156 223 247 301 364 456 511 589 655
Non Curr. Liab. 1 39 89 110 23 44 45 74 69 -10
Curr. Liab. 260 234 202 219 268 367 373 392 484 435
Minority Int.
Equity & Liab. 412 429 514 575 591 776 874 977 1,142 1,081
Non Curr. Assets 148 162 250 243 178 193 186 212 206 127
Curr. Assets 263 267 263 333 413 582 689 765 936 954
Misc. Exp. not W/O
Total Assets 412 429 514 575 591 776 874 977 1,142 1,081

Astrazeneca Pharma India Ltd. Profit and Loss

Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-12 Rs. Cr. TTM
Net Sales 517 564 544 571 728 832 814 806 1,003 1,197
Other Income 8 7 14 12 16 13 13 15 26 34
Total Income 525 571 558 583 745 845 826 820 1,029 1,231
Total Expenditure -531 -547 -507 -525 -657 -711 -678 -719 -838 -1,002
PBIDT -6 23 51 59 88 134 148 101 191 229
Interest -1 -1 -1 -1 -1
Depreciation -15 -17 -16 -15 -15 -19 -20 -17 -16 -15
Taxation -1 -15 -18 -18 -42 -34 -21 -35 -49
Exceptional Items -40 -24
PAT -21 5 20 26 54 72 93 62 99 139
Adjusted EPS -8 2 8 10 22 29 37 25 40 56

Astrazeneca Pharma India Ltd. Cash Flow

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr.
Cash Fr. Operatn. -1 -46 57 38 9 55 87 105 101 58
Cash Fr. Inv. -15 -19 -4 0 -9 4 -171 173 5 18
Cash Fr. Finan. 86 -1 -6 -9 -9 -24
Net Change 71 -64 53 38 -1 59 -90 269 96 52
Cash & Cash Eqvt 88 23 76 115 114 173 84 352 448 500

Astrazeneca Pharma India Ltd. Shareholding Pattern

9 Qtrs 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%) 2023-03 (%) 2023-06 (%) 2023-09 (%) 2023-12 (%)
Promoter 75.00 75.00 75.00 75.00 75.00 75.00 75.00 75.00 75.00
Public 25.00 25.00 25.00 25.00 25.00 25.00 25.00 25.00 25.00
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Astrazeneca Pharma India Ltd. Announcements

Fri, 23 Feb 2024
Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 ('SEBI Listing Regulations')
Please find the enclosed letter of the Company in relation to the captioned subject for your reference.
Thu, 22 Feb 2024
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Pursuant to Regulation 39(3) and other applicable regulations of SEBI (LODR) Regulations 2015 we would like to inform you that the Registrar and Share Transfer Agents of the Company Integrated Registry Management Services Private Limited have informed the Company on the enclosed request for Loss of Share Certificate from the claimant.Further subject to the completion of required formalities by the shareholder the Company will issue Letter of Confirmation thereof.
Tue, 20 Feb 2024
Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 - Change In Role Of Senior Management Personnel
Pursuant to Regulation 30 of SEBI (LODR) Regulations 2015 we would like to inform you on the change in role of Mr. Amit Bhakri currently the Business Unit Director - Biopharmaceutical Business Unit. He will be transitioning from the said role with effect from the close of business hours on March 31 2024 as he takes up another responsibility within AstraZeneca group.Further we wish to inform you that based on the recommendation of the Nomination and Remuneration Committee the Board of Directors of the Company have approved the appointment of Mr. Ayush Kumar Agarwal as Business Unit Director - Biopharmaceutical Business Unit with effect from April 1 2024.

Astrazeneca Pharma India Ltd. Technical Scans

Mon, 26 Feb 2024
Opening at High Opening at High
Closing Below Previous Low Closing Below Previous Low
Close Below Last Month Low Close Below Last Month Low
Opening at High for 2 Days Opening at High for 2 Days
High Decrease in 1 Month High Decrease in 1 Month

Astrazeneca Pharma India Ltd. Related Stocks

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 373,564.46 1,579.10 +1.4%
Cipla Ltd. 118,662.53 1,488.95 +1.3%
Dr. Reddy's Laboratories Ltd. 107,402.65 6,441.20 +0.0%
Zydus Lifesciences Ltd. 95,410.36 942.50 0.0%
Divi's Laboratories Ltd. 94,984.66 3,537.95 -1.1%
Apollo Hospitals Enterprise Ltd. 94,585.14 6,615.05 +0.6%
Torrent Pharmaceuticals Ltd. 88,769.16 2,618.00 -0.2%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-12 41.94 1,579.10 +1.4%
Cipla Ltd. Consolidated 2023-12 32.00 1,488.95 +1.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-12 20.54 6,441.20 +0.0%
Zydus Lifesciences Ltd. Consolidated 2023-12 32.08 942.50 0.0%
Divi's Laboratories Ltd. Consolidated 2023-12 68.68 3,537.95 -1.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-12 119.83 6,615.05 +0.6%
Torrent Pharmaceuticals Ltd. Consolidated 2023-12 59.42 2,618.00 -0.2%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-12 5.99 1,579.10 +1.4%
Cipla Ltd. Consolidated 2023-12 4.58 1,488.95 +1.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-12 4.00 6,441.20 +0.0%
Zydus Lifesciences Ltd. Consolidated 2023-12 4.91 942.50 0.0%
Divi's Laboratories Ltd. Consolidated 2023-12 7.29 3,537.95 -1.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-12 14.00 6,615.05 +0.6%
Torrent Pharmaceuticals Ltd. Consolidated 2023-12 12.41 2,618.00 -0.2%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 0.11 1,579.10 +1.4%
Cipla Ltd. Consolidated 2023-03 0.02 1,488.95 +1.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 0.06 6,441.20 +0.0%
Zydus Lifesciences Ltd. Consolidated 2023-03 0.07 942.50 0.0%
Divi's Laboratories Ltd. Consolidated 2023-03 0.00 3,537.95 -1.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 0.44 6,615.05 +0.6%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 0.85 2,618.00 -0.2%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,579.10 +1.4%
Cipla Ltd. Consolidated 2023-03 12.85 1,488.95 +1.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 6,441.20 +0.0%
Zydus Lifesciences Ltd. Consolidated 2023-03 11.60 942.50 0.0%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,537.95 -1.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 6,615.05 +0.6%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 2,618.00 -0.2%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,579.10 +1.4%
Cipla Ltd. Consolidated 2023-03 12.85 1,488.95 +1.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 6,441.20 +0.0%
Zydus Lifesciences Ltd. Consolidated 2023-03 11.60 942.50 0.0%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,537.95 -1.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 6,615.05 +0.6%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 2,618.00 -0.2%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 43,885.68 1,579.10 +1.4%
Cipla Ltd. Consolidated 2023-03 22,753.12 1,488.95 +1.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 24,669.70 6,441.20 +0.0%
Zydus Lifesciences Ltd. Consolidated 2023-03 17,237.40 942.50 0.0%
Divi's Laboratories Ltd. Consolidated 2023-03 7,767.51 3,537.95 -1.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 16,612.50 6,615.05 +0.6%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 9,620.15 2,618.00 -0.2%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 8,560.84 1,579.10 +1.4%
Cipla Ltd. Consolidated 2023-03 2,835.49 1,488.95 +1.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 4,507.30 6,441.20 +0.0%
Zydus Lifesciences Ltd. Consolidated 2023-03 2,001.90 942.50 0.0%
Divi's Laboratories Ltd. Consolidated 2023-03 1,823.38 3,537.95 -1.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 887.50 6,615.05 +0.6%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 1,245.23 2,618.00 -0.2%

Astrazeneca Pharma India Ltd. FAQ's

What is Astrazeneca Pharma I share price?

Can I buy Astrazeneca Pharma I shares now?

What is the Dividend Yield of Astrazeneca Pharma I?

What is the Market Cap of Astrazeneca Pharma I?

What are the key metrics to analyse Astrazeneca Pharma I?

What is the 52 Week High and Low of Astrazeneca Pharma I?

What is the trend of Astrazeneca Pharma I share price?